These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 12687404)

  • 1. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y; Nakajima K; Fukada T; Hibi M; Hirano T
    EMBO J; 1996 Apr; 15(7):1557-65. PubMed ID: 8612579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
    Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
    J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
    Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
    Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N; Bonavida B; Ciliberto G; Toniatti C; Travali S; D'Alessandro N
    Cancer; 1999 Jan; 85(1):134-44. PubMed ID: 9921985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
    Nakashima K; Taga T
    Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
    Yin T; Taga T; Tsang ML; Yasukawa K; Kishimoto T; Yang YC
    J Immunol; 1993 Sep; 151(5):2555-61. PubMed ID: 8360477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 6 and its receptor: ten years later.
    Hirano T
    Int Rev Immunol; 1998; 16(3-4):249-84. PubMed ID: 9505191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The soluble IL-6 receptors: serum levels and biological function.
    Montero-Julian FA
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):583-97. PubMed ID: 11502067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
    Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
    Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in interleukin-6 therapy].
    Ogata A; Nishimoto N; Yoshizaki K
    Rinsho Byori; 1999 Apr; 47(4):321-6. PubMed ID: 10340005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal gp130 signaling and autoimmune disease].
    Ishihara K; Atsumi T
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2336-42. PubMed ID: 12518458
    [No Abstract]   [Full Text] [Related]  

  • 20. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
    Skiniotis G; Boulanger MJ; Garcia KC; Walz T
    Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.